Ampicillin Sodium Injection — FDA Drug Shortage

To Be Discontinued — Sandoz Inc.

The FDA lists a drug shortage record for Ampicillin Sodium Injection (injection) from Sandoz Inc. with status To Be Discontinued. The shortage was first posted on Dec 8, 2025.

Shortage details

Status
To Be Discontinued
Company
Sandoz Inc.
Package NDC
0781-9413-92
Dosage Form
Injection
Presentation
Ampicillin Sodium, Injection, 2 g (NDC 0781-9413-92)
Initial Posting
Dec 8, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.